Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ocugen Inc 11 GREAT VALLEY PARKWAY MALVERN PA 19355 USA

ocugen.com Employees: 116 P: 484-328-4701

Sector:

Medical

Description:

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly known as Histogenics Cp, is based in Malvern, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 544,309
Enterprise Value, $K 554,529
Shares Outstanding, K 327,897
Float, K 313,830
% Float 95.71%
Short Interest, K 49,062
Short Float 15.71%
Days to Cover 14.96
Short Volume Ratio 0.39
% of Insider Shareholders 4.29%
% of Institutional Shareholders 10.27%

Financials:

Annual Sales, $ 4,410 K
Annual Net Income, $ -67,850 K
Last Quarter Sales, $ 1,750 K
Last Quarter Net Income, $ -20,050 K
EBIT, $ -59,770 K
EBITDA, $ -56,020 K

Growth:

1-Year Return 201.94%
3-Year Return 71.47%
5-Year Return -81.39%
5-Year Revenue Growth 10,925.00%
5-Year Earnings Growth 25.81%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 11/05/25
Next Earnings Date 05/08/26
Earnings Per Share ttm -0.22
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year -20.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-60 on 09/30/19

OCGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2,626.38%
Return-on-Assets % -123.83%
Profit Margin % -1,331.28%
Debt/Equity 8.05
Price/Sales 119.63
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.01
Interest Coverage -12.07
60-Month Beta 2.75
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar